DENND2D Antibodies

Santa Cruz Biotechnology delivers a wide array of DENND2D monoclonal antibodies for investigating DENND2D protein functions. DENND2D monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DENND2D is a member of the DENN (differentially expressed in normal and neoplastic cells) protein family, which plays a crucial role in regulating intracellular signaling pathways and membrane trafficking. DENND2D participates in the activation of small GTPases, which are essential for various cellular processes, including cell proliferation, differentiation, and migration. Research has shown that DENND2D expression levels can vary significantly between normal and cancer cells, making it an important focus in cancer research. Understanding DENND2D function and regulation provides valuable insights into cellular signaling mechanisms and their role in disease development. Investigating DENND2D activity helps researchers better understand its involvement in both normal cellular processes and pathological conditions. DENND2D research continues to reveal new aspects of cellular regulation and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of DENND2D's role in health and disease.